Moroccan Cannabis Medicine Gains in Milan
Farma 5, a Moroccan company, announced a significant milestone by producing a new epilepsy medication made from cannabis during its participation in the International Pharmaceutical Exhibition "CPHI" in Milan. This product is 100% Moroccan and developed from raw Moroccan materials. This achievement aims to enhance the position of national companies in the field of cannabis-derived pharmaceuticals, with scientific research directions including studies on other potential uses of cannabis for treating conditions such as autism, chronic pain, joint diseases, multiple sclerosis, and sleep disorders. This is in line with government encouragement for research collaborations.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)